Targeting of the WT191-138 fragment to human dendritic cells improves leukemia-specific T-cell responses providing an alternative approach to WT1-based vaccination.

Зохиогч

Dagvadorj, Nergui

Deuretzbacher, Anne

Weisenberger, Daniela

Baumeister, Elke

Trebing, Johannes

Lang, Isabell

Köchel, Carolin

Kapp, Markus

Kapp, Kerstin

Beilhack, Andreas

Hünig, Thomas

Einsele, Hermann

Wajant, Harald

Grigoleit, Götz Ulrich

Он

2017 оны гуравдугаар сар

Төрөл

journal article

Journal

Cancer immunology, immunotherapy : CII

Volume

66

Issue

3

Start Page

319

End Page

332

DOI

ISSN

1432-0851